Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Among nearly 200,000 individuals, daily use of low-dose aspirin was associated with an increased risk of major gastrointestinal or cerebral bleeding, according to a study in the June 6 issue of JAMA. The authors also found that patients with diabetes had a high rate of major bleeding, irrespective of aspirin use.
"Therapy with low-dose aspirin is used for the treatment of cardiovascular disease. It is recommended as a secondary prevention measure for individuals with moderate to high risk of cardiovascular events (i.e., for patients with multiple risk factors such as hypertension, dyslipidemia, obesity, diabetes, and family history of ischemic heart disease)," according to background information in the article. "Any benefit of low-dose aspirin might be offset by the risk of major bleeding.
http://www.sciencedaily.com/releases/2012/06/120605172017.htm
"Therapy with low-dose aspirin is used for the treatment of cardiovascular disease. It is recommended as a secondary prevention measure for individuals with moderate to high risk of cardiovascular events (i.e., for patients with multiple risk factors such as hypertension, dyslipidemia, obesity, diabetes, and family history of ischemic heart disease)," according to background information in the article. "Any benefit of low-dose aspirin might be offset by the risk of major bleeding.
http://www.sciencedaily.com/releases/2012/06/120605172017.htm